Stoke Therapeutics, Inc. STOK Q4 2025 Annual earnings
Reported March 16, 2026 · Before market open
Revenue estimate$5.8M
EPS estimate-$0.75
Next report
Aug 11, 2026 (in a month)Revenue estimate$5.4M
EPS estimate-$0.82
Financials
Q4 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Stoke Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Stoke Therapeutics, Inc. report Q4 2025 earnings?
- Stoke Therapeutics, Inc. (STOK) reported Q4 2025 earnings on March 16, 2026 before market open.
- What were Stoke Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Stoke Therapeutics, Inc. reported revenue of $1.4M and diluted EPS of $-0.97 for Q4 2025.
- Did Stoke Therapeutics, Inc. beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $5.8M by $4.4M. EPS missed the consensus estimate of $-0.75 by $0.22.
- How did Stoke Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 93.8% from $22.6M a year earlier and diluted EPS declined 438.9% from $-0.18.
- Where can I find Stoke Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001193125-26-108362) directly on SEC EDGAR. The filing index links above go to sec.gov.